BroadEye: An Ophthalmology Podcast

COVID-19 and The Low Vision Community: Perspectives Of A Congenitally Blind Researcher - Dr. Mahadeo Sukhai

Dr. Sukhai shares his journey from congenitally blind newborn to visually impaired biomedical researcher with a deep passion for science and inclusion. Dr. Sukhai further highlights recent research data surrounding the impact of COVID-19 on people with low vision.

 

http://broadeye.org/mahadeo/

How the Glaucoma Research Foundation Has Impacted Patient Care For More Than Four Decades - Tom Brunner

Tom Brunner, President and CEO of Glaucoma Research Foundation (GRF), shares the history of ophthalmic laser technology and how he ended up leading a global organization dedicated to funding promising Glaucoma research. Tom further provides a detailed overview of Glaucoma onset and progression, highlighting risk factors and the importance of early diagnosis. Some of the most significant clinical trials in Glaucoma in recent decades—funded by GRF—are also discussed.

 

http://broadeye.org/brunner/

Corneal Stem Cell Treatment, Paralympic Skiing and Blindness VS Low Vision - Mike May

Mike May is the Chief Evangelist at Goodmaps, founder of the Sendero group, a paralympic World Record holder in downhill skiing, and a serial entrepreneur who regained some vision after 43 years of blindness thanks to a novel corneal stem cell therapy. Mike discusses the impact of regaining some vision, highlighting the need for a diverse skill set to thrive in business, sports and life. 

 

http://broadeye.org/mikemay/

Blind Chess: Stories From Three Time US Champion Jim Thoune

In this episode, Jim Thoune describes his journey from a young boy who lost his vision due to Retinoblastoma to becoming a world class blind chess competitor. Jim discusses highlights from his career, how parents can help their blind children succeed, his passion for scuba diving, and much more.

 

http://broadeye.org/thoune/

Diabetic Retinopathy: Causes, Risk Factors, Treatment, and The Importance Of Early Diagnosis - Dr. Charles Wykoff

In this episode, Surgical and Medical Retina Specialist Dr. Charles Wykoff gives a detailed overview of Diabetic Retinopathy, with a particular focus on the importance of screening and early diagnosis to prevent blindness. Dr. Wykoff further discusses current treatments and therapies, his group's latest research findings, and how technology is changing the landscape for Diabetic Retinopathy and other ophthalmic diseases.

 

http://broadeye.org/wykoff/

Retinal Disease: New Horizons In the Bio-chemistry Of Vision - Dr. Stephen Redenti

Dr. Stephen Redenti, Professor of Biochemistry and Molecular Biology at The City University of New York, provides an overview of critical signaling processes that can shed light on retinal health and the origins of degenerative retinal disease. Dr. Redenti explores how decades of research into the biochemistry of tumor metastasis is now informing novel therapeutic approaches that aim to improve the success of stem cell therapies for Retinitis Pigmentosa and other ophthalmic diseases.

Age-related Macular Degeneration, Supplementation, and Key Research Findings in the Field of Ocular Nutrition - Prof. John Nolan

Professor John Nolan, Founder and Director of the Nutrition Research Centre Ireland (NRCI), explores the current research in the field of ocular nutrition, highlighting the potential for three specific carotenoids to significantly impact vision in patients with Age-related Macular Degeneration as well as the general adult population. Prof. Nolan further discusses why better regulatory oversight is needed for ocular health supplements, as well as key research findings that every optometrist and ophthalmologist should understand.

Skiing Blind: Mac Marcoux On The Need For Speed, Chasing Medals and Having Fun

Macmilton "Mac" Marcoux is a Canadian Paralympic alpine skier who has collected many Olympic medals and world titles at only 24 years. He started skiing at the age of four but started to lose his sight due to Stargardt disease and became legally blind in 2007. That never stopped him from continuing to pursue his passions and dreams.

Amblyopia, Strabismus, and VR-based Visual Fields - Dr. Benjamin T. Backus From Vivid Vision

In this episode, Vivid Vision's Chief Science Officer Dr. Benjamin T. Backus explains how his company's technology has been used to treat Amblyopia and Strabismus using custom-built software integrated into portable VR headsets. Dr. Backus further highlights an unmet need for at-home visual field tests and how Vivid Vision is making this a reality. 

Low Vision and Technology; How eSight Is Bridging the Gap To Bring Sight To the Visually Imparied

In this episode, eSight user and coach Richard Weatherford and company CCO Brian McCollum provide an overview of eSight technology and how it can be life-changing for people with poor central vision due to degenerative retinal disease. The guests explore use cases for the technology, how the core offering has evolved over time, and how people living with low vision can connect with the company to demo the latest model.